Bloom Energy Shares Plunge 18% After Hitting All-Time High Before Q4 Report

BEBE

Bloom Energy shares fell 18.51% on Wednesday after rebounding to an all-time high on Tuesday, reflecting investor caution ahead of Thursday’s Q4 report. Analysts forecast Q4 EPS of $0.24 (vs. $0.43 YoY) on $646.84M revenue, while its last quarter beat EPS and revenue estimates by $0.10 and $99M, respectively.

1. Stock Plunge Ahead of Earnings

Bloom Energy shares plunged by over 18% on Wednesday, reversing course from the prior day’s 6.8% surge to an all-time high. The sudden reversal reflects investor caution as the company prepares to report fourth-quarter results on Thursday. The drop represents one of the largest single-day declines in the past year, underscoring market sensitivity to upcoming financial disclosures.

2. Earnings Forecast and Historical Performance

Wall Street analysts expect fourth-quarter earnings per share of $0.24, down from $0.43 in the year-ago period, while revenue is forecast at approximately $647 million, up from $572 million a year earlier. Bloom Energy has beaten consensus EPS estimates in each of the last four quarters, delivering an average upside surprise of 1.8%. In the prior quarter, the company reported EPS of $0.15 against expectations of $0.05 and generated revenue of $519 million versus a $421 million consensus.

3. Technical Momentum Signals

Technical indicators present a mixed outlook for the stock. The Relative Strength Index stands near 69, which traders view as neutral but approaching overbought territory. Meanwhile, the Moving Average Convergence Divergence line remains above its signal, indicating underlying bullish momentum. Key chart levels to watch include resistance near $148 and support around $136.50, levels that could influence trading ranges in the near term.

4. Analyst Ratings and Price Targets

The consensus recommendation on Bloom Energy is Hold, with the average price target set at $79.81. Recent analyst actions include a neutral rating with a target of $133 from Roth Capital on February 3, a Buy initiation with a $207 target from China Renaissance on January 28, and an equal-weight initiation with a $153 target from Barclays on the same date. These divergent views reflect differing opinions on the company’s ability to sustain growth and justify its premium valuation.

Sources

BZZ